Effects of Metformin, Pioglitazone and Aqueous Extract of Delonix Regia on Blood Levels of Glycated Hemoglobin (Hba1c) of Streptozotocin-Induced Diabetic Male and Female Wistar Albino Rats
Abstract
The effects of Delonix regia extract (d200mg, d300mg, and d400mg), metformin (m8.3mg, m12.5mg and m16.5mg), pioglitazone (p0.5mg, p0.7mg and p0.9mg) and combined formulation of metformin and extract (m6.25d150mg) on glycated hemoglobin status in streptozotocin-induced diabetic Albino wistar rats. Diabetic status of these rats was assessed by estimating fasting blood glucose levels. A total of 150 albino rats were used for the investigation and were grouped into twelve groups of twelve rats each as follows; Group I: normal control rats (NCR). Group II: Diabetic control rats (DCR). Group III: Diabetic rats treated with d200mg. Group IV: Diabetic rats treated with d300mg. Group V: Diabetic rats treated with d400mg. Group VI: Diabetic rats treated with m8.3mg. Group VII: Diabetic rats treated with m12.5mg. Group VIII: Diabetic rats treated with m16.5mg. Group IX: Diabetic rats treated with p0.5mg. Group X: Diabetic rats treated with p0.75mg. Group XI: Diabetic rats treated with p1.0mg. Group XII: Diabetic rats treated with m125d300mg each for male and female respectively, for a total of 56 days. After every two weeks interval of treatment for eight weeks three rats from each group were sacrificed and blood sample were collected and analyzed for various parameters. The result obtained showed an elevated level of glycated hemoglobin in diabetic-induced wistar albino rats compared with normal control rats. However, there was reversal of the effects when treated with the…
How strong is the evidence?
Evidence Hub reads this as a dataset, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.